Review Article
Volume 4 Issue 12 - 2021
A Comprehensive Review of Specific Herbal Medicines with Immunomodulatory Effects, and COVID-19
Nicholas A Kerna1,2*, Joseph Anderson II3, Kevin D Pruitt4,5, Hilary M Holets6,7, ND Victor Carsrud8, Raymond Nomel9, Uzoamaka Nwokorie10 and John V Flores6,7
1SMC–Medical Research, Thailand
2First InterHealth Group, Thailand
3International Institute of Original Medicine, USA
4Kemet Medical Consultants, USA
5PBJ Medical Associates, LLC, USA
6Beverly Hills Wellness Surgical Institute, USA
7Orange Partners Surgicenter, USA
8Lakeline Wellness Center, USA
9All Saints University, College of Medicine, St. Vincent and the Grenadines
10University of Washington, USA
*Corresponding Author: Nicholas A Kerna, (mailing address) POB47 Phatphong, Suriwongse Road, Bangkok, Thailand 10500.
Received: September 21, 2021; Published: November 30, 2021




Abstract

In contemporary times, herbal medicine is used as an adjunct to conventional therapy and for health promotion. Herbs that have long been considered curative or prophylactic should be further studied in clinical trials. Can these time-tested natural therapies be used and trusted in exceptional circumstances, such as the ongoing COVID-19 pandemic?

Traditional medicines have led to a revolution in and evolution of modern medicine. Herbs, such as Echinacea purpurea, Curcuma longa, Allium sativum, Althaea officinalis, Andrographis paniculate, Commiphora molmol, Cymbopogon citratus, Eucalyptus globulus, have shown immunomodulatory effects. Many plant-based formulations with potential immunomodulatory activity have been isolated and utilized—even without supportive evidence-based findings. Thus, more initiative toward human trials should be undertaken to understand better how herbs promote human health and prevent or cure specific illnesses and diseases.

Moreover, and most importantly, the interests of indigenous communities—which are the primary source of rich traditional knowledge and the natural reserve of herbal plants—should be safeguarded.

Keywords: Mangosteen; Natural Remedy; Phytotherapeutic; Thai; Traditional; Vedas

References

  1. Introduction and Importance of Medicinal Plants and Herbs (2021).https://www.nhp.gov.in/introduction-and-importance-of-medicinal-plants-and-herbs_mtl
  2. Stojanoski N. “Development of health culture in Veles and its region from the past to the end of the 20th century”. Veles: Society of science and art (1999): 13-34.
  3. Sharma P., et al. “Immunomodulators: Role of medicinal plants in the immune system”. National Journal of Physiology, Pharmacy and Pharmacology 6 (2017): 552-556. http://njppp.com/fulltext/28-1487571016.pdf
  4. Calixto JB. “Efficacy, safety, quality control, marketing, and regulatory guidelines for herbal medicines (phytotherapeutic agents)”. The Brazilian Journal of Medical and Biological Research 2 (2000). https://pubmed.ncbi.nlm.nih.gov/10657057/
  5. BB Petrovska. “Historical review of medicinal plants’ usage”. Pharmacognosy Reviews 11 (2012): 1-5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358962/
  6. Ekor M. “The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety”. Frontiers in Pharmacology 4 (2013): 177. https://pubmed.ncbi.nlm.nih.gov/24454289/
  7. Kelly K. “History of medicine”. New York: Facts on file (2009): 29-50.
  8. Thorwald J. “Power and knowledge of ancient physicians”. Zagreb: August Cesarec (1991): 10-255.
  9. Haddad PS., et al. “Natural health products, modulation of immune function and prevention of chronic diseases”. Evidence-Based Complementary and Alternative Medicine 4 (2005): 513-520. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297498/
  10. Singh N. “A Review On Herbal Plants Used As Immunomodulators”. International Journal of Pharmaceutical Research 02 (2021): 3602-3610. http://www.ijpronline.com/ViewArticleDetail.aspx?ID=20830
  11. Xiao C., et al. “Medical Plants and Immunological Regulation”. Journal of Immunology Research Volume (2018). https://www.hindawi.com/journals/jir/si/694170/
  12. Davis L and Kuttan G. “Immunomodulatory activity of Withania somnifera”. Journal of Ethnopharmacology 71 (2000): 193-200. https://pubmed.ncbi.nlm.nih.gov/10904163/
  13. Singh UP., et al. “Role of garlic (Allium sativum L.) in human and plant diseases”. Indian Journal of Experimental Biology 4 (2001): 310-322. https://pubmed.ncbi.nlm.nih.gov/11491574/
  14. Liu P., et al. “Chemical constituents, biological activity and agricultural cultivation of Aloe vera- A review”. Asian Journal of Chemistry 112 (2013): 6477. http://www.asianjournalofchemistry.co.in/User/ViewFreeArticle.aspx?ArticleID=25_13_1
  15. Thakur M., et al. “Immunomodulatory activity of Chlorophytum borivilianum Sant. F”. Evidence-Based Complementary and Alternative Medicine4 (2007): 419-423. https://pubmed.ncbi.nlm.nih.gov/18227908/
  16. Boskabady MH., et al. “The effects of Curcuma Longa L. and its constituents in respiratory disorders and molecular mechanisms of their action”. In Studies in Natural Products Chemistry; Atta-ur-Rahman, Edition. Elsevier: Oxford, UK 65 (2020): 239-269. https://www.researchgate.net/publication/342401858_The_effects_of_Curcuma_Longa_L_and_its_constituents_in_respiratory_disorders_and_molecular_mechanisms_of_their_action
  17. Sharma MSA., et al. “Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract”. Antiviral Research2 (2009): 165-170. https://pubmed.ncbi.nlm.nih.gov/19409931/
  18. Rattis BAC., et al. “Curcumin as a Potential Treatment for COVID-19”. Frontiers in Pharmacology 12 (2021): 1-14. https://pubmed.ncbi.nlm.nih.gov/34025433/
  19. Valizadeh H., et al. “Nano-curcumin Therapy, a Promising Method in Modulating Inflammatory Cytokines in COVID-19 Patients”. International Immunopharmacology 89 (2020): 107088. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574843/
  20. Burger RA., et al. “Echinacea-induced cytokine production by human macrophages”. International Journal of Immunopharma- Cology7 (1997): 371-379. https://pubmed.ncbi.nlm.nih.gov/9568541/
  21. Back AT and Lundkvist A. “Dengue viruses-an an overview”. Infection Ecology and Epidemiology 3 (2013): 19839. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759171/
  22. Pu WL., et al. “Anti-inflammatory effects of Rhodiola rosea L.: A review”. Biomedicine and Pharmacotherapy 121 (2020): 109552. https://pubmed.ncbi.nlm.nih.gov/31715370/
  23. Aucoin M., et al. “The effect of Echinacea spp. on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review”. Advances in Integrative Medicine 4 (2020): 203-217. https://pubmed.ncbi.nlm.nih.gov/32837894/
  24. Silveira D., et al. “COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?” Frontiers in Pharmacology 11 (2020): 1-44. https://www.frontiersin.org/articles/10.3389/fphar.2020.581840/full
  25. EMA (2016c). “European Union herbal monograph on Althaea officinalis L., radix,” in EMA/HMPC/436679/2015 Committee on Herbal Medicinal Products (HMPC) (London: European Medicines Agency) (2016c). https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-althaea-officinalis-l-radix_en.pdf
  26. Monographs on selected medicinal plants 2 (Geneva: World Health Organization) (2002). http://apps.who.int/iris/bitstream/handle/10665/42052/9241545178.pdf;jsessionid=BC0DFB602E5A4372D83467D9025036EC?sequence=1
  27. Su S., et al. “Anti-inflammatory and analgesic activity of different extracts of Commiphora myrrha”. Journal of Ethnopharmacology 134 (2011): 251-258. https://pubmed.ncbi.nlm.nih.gov/21167270/
  28. Silva FFM., et al. “Analysis of chemical composition of the essential oil of holy grass (Cymbopogon citratus) obtained through extractor for water vapor trail with built with materials of acquisition and easy low cost”. Holos 30 (2014): 144. https://www.proquest.com/docview/1612531245
  29. HHDC (2018). Information on Ethnic Group Populations in 20 Provinces (In Thai) (2021).
  30. Phumthum M., et al. “Medicinal Plants Used for Treating Mild Covid-19 Symptoms Among Thai Karen and Hmong”. Frontiers in Pharmacology 12 (2021): 699897. https://www.frontiersin.org/articles/10.3389/fphar.2021.699897/full
  31. Shi TH., et al. “Andrographolide and its Fluorescent Derivative Inhibit the Main Proteases of 2019-nCoV and SARS-CoV through Covalent Linkage”. Biochemical and Biophysical Research Communications 3 (2020): 467-473. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447262/
  32. Khorrami S., et al. “Sesame seeds essential oil and Sesamol modulate the pro-inflammatory function of macrophages and dendritic cells and promote Th2 response”. The Medical Journal of the Islamic Republic of Iran 1 (2018): 1-8. https://pubmed.ncbi.nlm.nih.gov/30788333/
  33. Pathak N., et al. “Value addition in sesame: A perspective on bioactive components for enhancing utility and profitability”. Pharmacognosy Reviews 16 (2014): 147-155. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127822/
  34. Kanjanasirirat P., et al. “High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents”. Scientific Reports 1 (2020): 1-12. https://pubmed.ncbi.nlm.nih.gov/33203926/
  35. Hu XY., et al. “Andrographis paniculata (Chuān Xīn Lián) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysis”. PLoS One8 2(2017): e0181780. https://pubmed.ncbi.nlm.nih.gov/28783743/
  36. Andrographis paniculata (Burm. F.) Wall. Ex Nees, Andrographolide, and Andrographolide Analogues as SARS-CoV-2 Antivirals? A Rapid Review Xin Yi Lim, Janice Sue Wen Chan, Terence Yew Chin Tan et al”. Natural Product Communications5 (2021): 1-15. https://journals.sagepub.com/doi/full/10.1177/1934578X211016610
  37. Pedraza-Chaverri J., et al. “Medicinal properties of mangosteen (Garcinia mangostana)”. Food and Chemical Toxicology 46 (2008): 3227-3239. https://pubmed.ncbi.nlm.nih.gov/18725264/
  38. Tang YP., et al. “Effect of a mangosteen dietary supplement on human immune function: a randomized, double-blind, placebo-controlled trial”. Journal of Medicinal Food 4 (2009): 755-763. https://pubmed.ncbi.nlm.nih.gov/19697997/
  39. Balekundri A and Mannur VK. “Quality control of the traditional herbs and herbal products: a review”. Future Journal of Pharmaceutical Sciences 6 (2020): 67. https://fjps.springeropen.com/articles/10.1186/s43094-020-00091-5
  40. Quality control methods for herbal materials (2011).
  41. Che CT., et al. “Herb-Herb Combination for Therapeutic Enhancement and Advancement: Theory, Practice, and Future Perspectives”. Molecules5 (2013): 5125-5141. https://pubmed.ncbi.nlm.nih.gov/23644978/
  42. Lou SK., et al. “An integrated web medicinal materials DNA database: MMDBD (Medicinal Materials DNA Barcode Database)”. BMC Genomics 11 (2010): 402. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996930/
  43. Myers N. “The world's forests and human population: the environmental interconnections”. Population and Development Review 16 (1991): 1-15. https://www.jstor.org/stable/2808073
  44. Farooquee NA., et al. “Indigenous knowledge systems and sustainable management of natural resources in a high altitude society in Kumaun Himalaya, India”. Journal of Human Ecology 16 (2004): 33-42. https://www.tandfonline.com/doi/abs/10.1080/09709274.2004.11905713
  45. Kala CP., et al. “Developing the medicinal plants' sector in northern India: challenges and opportunities”. Journal of Ethnobiology and Ethnomedicine 2 (2006): 32. https://ethnobiomed.biomedcentral.com/articles/10.1186/1746-4269-2-32
  46. State of the World's Forest. Rome: Food and Agricultural Organization (2003). https://www.fao.org/3/y7581e/y7581e.pdf
  47. Bulletin 350. Royal Tropical Institute, Amsterdam, The Netherlands; 2003. Cultivating a Healthy Enterprise (2003).
  48. Kala CP. “Assessment of species rarity”. Current Science 86 (2004): 1058-1059.
  49. Hamilton AC. “Medicinal plants, conservation and livelihoods”. Biodiversity and Conservation 13 (2004): 1477-1517. https://link.springer.com/article/10.1023/B:BIOC.0000021333.23413.42
  50. Schippmann U., et al. “Impact of cultivation and Gathering of Medicinal Plants on Biodiversity: Global Trends and Issues. Rome: Inter-Department Working Group on Biology Diversity for Food and Agriculture, FAO (2002). https://www.fao.org/3/AA010E/AA010e00.htm
  51. Rao MR., et al. “Medicinal and aromatic plants in agroforestry systems”. Agroforestry Systems 61 (2004): 107-122. https://www.researchgate.net/publication/226462494_Medicinal_and_aromatic_plants_in_agroforestry_systems
  52. Koo B., et al. “Intellectual property. Plants and intellectual property: an international appraisal”. Science5700 (2004): 1295-1297. https://pubmed.ncbi.nlm.nih.gov/15550646/
  53. Karimi A., et al. “Herbal versus synthetic drugs; beliefs and facts”. Journal of Nephropharmacology 1 (2015): 27-30. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297475/
  54. Izzo AA. “Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data”. Medical Principles and Practice 21 (2012): 404-428. https://pubmed.ncbi.nlm.nih.gov/22236736/
  55. Lee A., et al. “Possible interaction between sevoflurane and Aloe vera”. Annals of Pharmacotherapy 38 (2004): 1651-1654. https://pubmed.ncbi.nlm.nih.gov/15292490/
  56. López Galera RM., et al. “Interaction between cat’s claw and protease inhibitors atazanavir, ritonavir and saquinavir”. European Journal of Clinical Pharmacology 64 (2008): 1235-1236. https://pubmed.ncbi.nlm.nih.gov/18712519/
  57. Hajda J., et al. “Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans”. European Journal of Pharmaceutical Sciences 41 (2010): 729-735. https://www.researchgate.net/publication/47382303_Garlic_extract_induces_intestinal_P-glycoprotein_but_exhibits_no_effect_on_intestinal_and_hepatic_CYP3A4_in_humans
  58. Taylor JR and Wilt VM. “Probable antagonism of warfarin by green tea”. Annals of Pharmacotherapy 33 (1999): 426-428. https://pubmed.ncbi.nlm.nih.gov/10332534/
  59. Werba JP., et al. “The effect of green tea on simvastatin tolerability”. Annals of Internal Medicine 149 (2008): 286-287. https://pubmed.ncbi.nlm.nih.gov/18711168/
  60. Guidelines on good agricultural and collection practices (GACP) for medicinal plants. WHO guidelines on good agricultural and collection practices. Geneva GACP 1-71 (2003). http://apps.who.int/iris/bitstream/handle/10665/42783/9241546271.pdf?sequence=1
  61. WHO Traditional Medicine Strategy 2014-2023. Traditional Medicine Strategy 2019 (2021). https://www.who.int/publications/i/item/9789241506096
  62. Guidelines for ATC classification and DDD assignment 2013. WHO Collaborating Centre for Drug Statistics Methodology”. Drug Statistics Methodology (2012). https://www.whocc.no/filearchive/publications/1_2013guidelines.pdf
  63. Geneva: WHO Library Cataloguing-in-Publication Data, World Health Organization; 2005. [Last cited on 2014 Apr 29]. Guidelines on the Registration of Traditionally used Herbal Products, Department of Health, Republic of Philippines, Report of a WHO Global Survey (2021). https://apps.who.int/iris/bitstream/handle/10665/92455/9789241506090_eng.pdf
  64. Malik V, editor. 23rd Lucknow: Eastern Book Company. Law Relating to Drugs and Cosmetics (2013).
  65. Ishak R and Mohamad J. “Guidelines on Registration of Traditional and Health Supplement Products”. Revised ed. Version 1.0. Kuala Lumpur. Malaysian Biotechnology Corporation SDN BH (2011). http://www.biotechcorp.com.my/wp.content/uploads/2011/11/guidelines-on-registration-of-traditional-health-supplement-product-Dec-2011-Revision.pdf
  66. Health Sciences Authority. Regulatory guidelines (2021). https://www.hsa.gov.sg/docs/default-source/hprg-tpb/guidances/guidance-on-therapeutic-product-registration-in-singapore_aug21.pdf
  67. Ramadoss MSK and Koumaravelou K. “Regulatory compliance of herbal medicines–A review”. International Journal of Research in Pharmaceutical Sciences 4 (2019): 3127-3135. https://pharmascope.org/index.php/ijrps/article/view/1609
Citation: Kerna NA, Anderson II J, Pruitt KD, Holets HM, Carsrud NDV, Nomel R, Nwokorie U, Flores JV. ““A Comprehensive Review of Specific Herbal Medicines with Immunomodulatory Effects, and COVID-19”. EC Clinical and Medical Case Reports 4.12 (2021): 50-62.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 25, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.